Invuity’s patented Intelligent Photonics® devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the strengthening of its executive management team with the appointment of Marcia Fish as Chief Human Resources Officer, effective October 2, 2017. She will report to Invuity CEO Phillip Sawyer and will have direct responsibility for the company’s people strategy including talent acquisition, talent development and building organizational capability to further support Invuity’s growth. Mr. Sawyer said, “We are thrilled to have Marcia join our team and leverage her expertise from her work with both smaller and larger companie...Read More
SAN FRANCISCO, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it has drawn $10 million in additional borrowings under an amended debt agreement with MidCap Financial (“MidCap”). The MidCap facility consists of a $30 million term loan divided in two tranches. The first tranche of $20 million was funded upon closing of the original agreement on March 10, 2017. The $10 million second tranche was funded on September 26, 2017. The MidCap agreement requires the Company to maintain certain minimum net revenue requirements, which have been adjusted in the amended agreement. The MidCap f...Read More
SAN FRANCISCO, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the reintroduction and full commercial launch of PhotonBlade™, a dynamic precision illuminator with enhanced energy. This version of PhotonBlade includes enhancements to improve energy delivery and optimize illumination performance. The Company anticipates shipping product to customers in the next few weeks. PhotonBlade represents a new technology platform for Invuity, delivering directed, thermally cool illumination at the precise point of surgical treatment. PhotonBlade’s novel energy design consists of a proprietary in...Read More
“Invuity’s technology has allowed surgeons in both specialties the ability to use smaller and often fewer incisions and better preserve the viability of tissue in these more advanced procedures, resulting in better aesthetic outcomes.”
Long Island Plastics Institute
Garden City, NY
“Invuity’s Intelligent Photonics technology allows me to perform more minimally invasive spinal surgeries (MIS), including discectomies and fusions, with remarkable visualization. This is truly an enabling technology that allows me to expand my use of MIS and other advanced spine technologies, to the benefit of my patients.”
Chairman, Texas Back Institute Research Foundation
“The light improves my visualization in the surgical field, allowing me to be more precise with my bone cuts and joint preparation”